Advertisement

HFE hemochromatosis in African Americans: Prevalence estimates of iron overload and iron overload-related disease

Published:September 09, 2022DOI:https://doi.org/10.1016/j.amjms.2022.08.015

      Abstract

      Background

      Little is known about the prevalence of HFE (homeostatic iron regulator) hemochromatosis in African Americans (AA).

      Methods

      We defined AA as self-identified AA, blacks, or non-Hispanic blacks. We defined hemochromatosis-associated HFE genotypes as p.C282Y/p.C282Y and p.C282Y/p.H63D. We compiled prevalences of these genotypes in AA using published population and cohort data and numbers of men and women ≥18 y‬ in 2018 U.S. Census estimates. We defined iron overload (IO) and IO-related disease by genotype as previously reported in population and cohort studies of hemochromatosis in whites of European ancestry. We used these definitions to estimate prevalences and numbers of AA with IO and IO-related disease associated with hemochromatosis-associated HFE genotypes.

      Results

      There were ∼16,287,599 men and ∼17,644,898 women. HFE genotypes and their respective prevalences were: p.C282Y/p.C282Y, 0.00017 (6/34,905) [95% confidence interval 0.000034, 0.00031] and p.C282Y/p.H63D, 0.0012 (41/33,596) [0.000084, 0.0016]. IO prevalences were: men 0.000076 [0.000072, 0.000081] and women 0.0000061 [0.0000050, 0.0000073]. IO-related disease prevalences were: men 0.000063 [0.000059, 0.000067] and women 0.0000021 [0.0000014, 0.0000027]. There were ∼1021 [961, 1091] men and ∼36 [25, 48] women with IO-related disease.

      Conclusions

      We conclude that ∼1/25,061 AA >18 y have a hemochromatosis-associated HFE genotype and IO and that ∼1/32,103 AA >18 y have a hemochromatosis-associated HFE genotype and IO-related disease.

      Key Indexing Terms

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Edwards CQ
        • Barton JC.
        Hemochromatosis.
        in: Greer JP Rodgers GM Arber DA Wintrobe’s Clinical Hematology. 14th ed. Wolters Kluwer, Philadelphia2019: 665-690
        • Ganz T.
        Hepcidin and iron regulation, 10 years later.
        Blood. 2011; 117: 4425-4433
        • Feder JN
        • Gnirke A
        • Thomas W
        • et al.
        A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.
        Nat Genet. 1996; 13: 399-408
        • Barton JC
        • Edwards CQ
        • Acton RT.
        HFE gene: Structure, function, mutations, and associated iron abnormalities.
        Gene. 2015; 574: 179-192
        • Gurrin LC
        • Bertalli NA
        • Dalton GW
        • et al.
        HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity.
        Hepatology. 2009; 50: 94-101
        • Conrad ME.
        Sickle cell disease and hemochromatosis.
        Am J Hematol. 1991; 38: 150-152
        • Barton JC
        • Acton RT.
        Inheritance of two HFE mutations in African Americans: cases with hemochromatosis phenotypes and estimates of hemochromatosis phenotype frequency.
        Genet Med. 2001; 3: 294-300
        • Labowitz DA
        • Bontreger J
        • Min AD.
        An unusual case of hemochromatosis in an African-American man: case report and review of the literature.
        Dig Dis Sci. 2007; 52: 3519-3520
        • Barton JC
        • Acton RT
        • Dawkins FW
        • et al.
        Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study.
        Genet Test. 2005; 9: 231-241
        • World Medical Association
        Declaration of Helsinki: ethical principles for medical research involving human subjects.
        JAMA. 2013; 310: 2191-2194
        • Barton JC
        • Edwards C
        • Acton RT.
        Prevalences of hemochromatosis-associated HFE genotypes and hemochromatosis phenotypes in African Americans and European Americans based on published population and cohort studies.
        Open Science Framework. 2021;
      1. Karczewski KJ, Franciola LC, Tiao G, et al. Cold Spring Harbor Laboratory. The mutational constraint spectrum quantified from variation in 141,456 humans, https://doi.org/10.1101/531210; 2020 [accessed 5.22.20].

        • Lovejoy PE.
        Transformations in Slavery.
        Cambridge University Press, Cambridge2000
        • Allen KJ
        • Gurrin LC
        • Constantine CC
        • et al.
        Iron-overload-related disease in HFE hereditary hemochromatosis.
        N Engl J Med. 2008; 358: 221-230
      2. United States Census Bureau, Population Division. Annual Estimates of the Resident Population: April 1, 2010 to July 1, 2018: 2018 Population Estimates,https://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?src=bkmk; 2018 [accessed 8.3.21 A.D.].

      3. United States Census Bureau, Department of Commerce. Quick Facts. United States,https://www.census.gov/quickfacts/fact/table/US/IPE120217; 2019 [accessed 8.3.21].

        • Acton RT
        • Wiener HW
        • Barton JC.
        Estimates of European American ancestry in African Americans using HFE p.C282Y.
        Genet Test Mol Biomarkers. 2020; 24: 578-583
        • Merryweather-Clarke AT
        • Pointon JJ
        • Jouanolle AM
        • et al.
        Geography of HFE C282Y and H63D mutations.
        Genet Test. 2000; 4: 183-198
        • Merryweather-Clarke AT
        • Pointon JJ
        • Shearman JD
        • et al.
        Global prevalence of putative haemochromatosis mutations.
        J Med Genet. 1997; 34: 275-278
        • Barton JC
        • Shih WW
        • Sawada-Hirai R
        • et al.
        Genetic and clinical description of hemochromatosis probands and heterozygotes: evidence that multiple genes linked to the major histocompatibility complex are responsible for hemochromatosis.
        Blood Cells Mol Dis. 1997; 23: 135-145
        • Sham RL
        • Ou CY
        • Cappuccio J
        • et al.
        Correlation between genotype and phenotype in hereditary hemochromatosis: analysis of 61 cases.
        Blood Cells Mol Dis. 1997; 23: 314-320
        • Brissot P
        • Moirand R
        • Jouanolle AM
        • et al.
        A genotypic study of 217 unrelated probands diagnosed as “genetic hemochromatosis” on “classical” phenotypic criteria.
        J Hepatol. 1999; 30: 588-593
        • Kelley M
        • Joshi N
        • Xie Y
        • et al.
        Iron overload is rare in patients homozygous for the H63D mutation.
        Can J Gastroenterol Hepatol. 2014; 28: 198-202
        • Aguilar-Martinez P
        • Bismuth M
        • Picot MC
        • et al.
        Variable phenotypic presentation of iron overload in H63D homozygotes: are genetic modifiers the cause?.
        Gut. 2001; 48: 836-842
        • de Diego C
        • Opazo S
        • Murga MJ
        • et al.
        H63D homozygotes with hyperferritinaemia: Is this genotype, the primary cause of iron overload?.
        Eur J Haematol. 2007; 78: 66-71
        • Burke W
        • Imperatore G
        • McDonnell SM
        • et al.
        Contribution of different HFE genotypes to iron overload disease: a pooled analysis.
        Genet Med. 2000; 2: 271-277
        • Neghina AM
        • Anghel A.
        Hemochromatosis genotypes and risk of iron overload - a meta-analysis.
        Ann Epidemiol. 2011; 21: 1-14
        • Holmström P
        • Marmur J
        • Eggertsen G
        • et al.
        Mild iron overload in patients carrying the HFE S65C gene mutation: a retrospective study in patients with suspected iron overload and healthy controls.
        Gut. 2002; 51: 723-730
        • Beutler E
        • Felitti V
        • Gelbart T
        • et al.
        The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic.
        Ann Intern Med. 2000; 133: 329-337
        • Waalen J
        • Nordestgaard BG
        • Beutler E.
        The penetrance of hereditary hemochromatosis.
        Best Pract Res Clin Haematol. 2005; 18: 203-220
        • Beutler E
        • Barton JC
        • Felitti VJ
        • et al.
        Ferroportin 1 (SCL40A1) variant associated with iron overload in African-Americans.
        Blood Cells Mol Dis. 2003; 31: 305-309
        • Lee PL
        • Barton JC
        • Brandhagen D
        • et al.
        Hemojuvelin (HJV) mutations in persons of European, African-American and Asian ancestry with adult onset haemochromatosis.
        Br J Haematol. 2004; 127: 224-229
        • Monaghan KG
        • Rybicki BA
        • Shurafa M
        • et al.
        Mutation analysis of the HFE gene associated with hereditary hemochromatosis in African Americans.
        Am.J Hematol. 1998; 58: 213-217
        • Lee PL
        • Gaasterland T
        • Barton JC.
        Mild iron overload in an African American man with SLC40A1 D270V.
        Acta Haematol. 2012; 128: 28-32
        • Hitawala A
        • Alomari M
        • Khazaaleh S
        • et al.
        Hemochromatosis as an unusual cause of pancreatitis in an African-American female of child-bearing age.
        Cureus. 2020; 12: e7179
        • Beutler E
        • Gelbart T
        • West C
        • et al.
        Mutation analysis in hereditary hemochromatosis.
        Blood Cells Mol Dis. 1996; 22: 187-194
        • Barton JC
        • Acton RT
        • Rivers CA
        • et al.
        Genotypic and phenotypic heterogeneity of African Americans with primary iron overload.
        Blood Cells Mol Dis. 2003; 31: 310-319
        • Barton JC
        • Lafreniere SA
        • Leiendecker-Foster C
        • et al.
        HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants.
        Am J Hematol. 2009; 84: 710-714
        • Wallace DF
        • Subramaniam VN.
        The global prevalence of HFE and non-HFE hemochromatosis estimated from analysis of next-generation sequencing data.
        Genet Med. 2016; 18: 618-626
        • Beutler E
        • Gelbart T.
        A common intron 3 mutation (IVS3 -48c–>g) leads to misdiagnosis of the c.845G–>A (C282Y) HFE gene mutation.
        Blood Cells Mol Dis. 2000; 26: 229-233
        • Gordeuk V
        • Mukiibi J
        • Hasstedt SJ
        • et al.
        Iron overload in Africa. Interaction between a gene and dietary iron content.
        N Engl J Med. 1992; 326: 95-100
        • Baer DM
        • Simons JL
        • Staples RL
        • et al.
        Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older.
        Am J Med. 1995; 98: 464-468
        • Phatak PD
        • Sham RL
        • Raubertas RF
        • et al.
        Prevalence of hereditary hemochromatosis in 16031 primary care patients.
        Ann Intern Med. 1998; 129: 954-961
        • Barton JC
        • Cheatwood SM
        • Key TJ
        • et al.
        Hemochromatosis detection in a health screening program at an Alabama forest products mill.
        J Occup Environ Med. 2002; 44: 745-751
        • Murugan RC
        • Lee PL
        • Kalavar MR
        • et al.
        Early age-of-onset iron overload and homozygosity for the novel hemojuvelin mutation HJV R54X (exon 3; c.160A–>T) in an African American male of West Indies descent.
        Clin Genet. 2008; 74: 88-92
        • Majore S
        • Ricerca BM
        • Radio FC
        • et al.
        Type 3 hereditary hemochromatosis in a patient from sub-Saharan Africa: is there a link between African iron overload and TFR2 dysfunction?.
        Blood Cells Mol Dis. 2013; 50: 31-32
        • Zaahl MG
        • Merryweather-Clarke AT
        • Kotze MJ
        • et al.
        Analysis of genes implicated in iron regulation in individuals presenting with primary iron overload.
        Hum Genet. 2004; 115: 409-417
        • Perry GS
        • Byers T
        • Yip R
        • et al.
        Iron nutrition does not account for the hemoglobin differences between blacks and whites.
        J Nutr. 1992; 122: 1417-1424
        • Ahluwalia N
        • Sternberg M
        • Raghavan R
        • et al.
        Race-ethnic patterns in iron intake and status in US women: findings from NHANES 2003-06.
        FASEB J. 2015; 29 (272.6)
        • National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism
        Alcohol Use and Alcohol Use Disorders in the United States: Main Findings from the 2001-2002.
        National Epidemiologic Survey on Alcohol and Related Conditions (NESARC), 2006 ([accessed 8.3.21])
        • Beutler E
        • West C.
        Hematologic differences between African-Americans and whites: the roles of iron deficiency and alpha-thalassemia on hemoglobin levels and mean corpuscular volume.
        Blood. 2005; 106: 740-745
        • Shan Y
        • Lambrecht RW
        • Bonkovsky HL.
        Association of hepatitis C virus infection with serum iron status: analysis of data from the Third National Health and Nutrition Examination Survey.
        Clin Infect Dis. 2005; 40: 834-841
        • Bulaj ZJ
        • Ajioka RS
        • Phillips JD
        • et al.
        Disease-related conditions in relatives of patients with hemochromatosis.
        N Engl J Med. 2000; 343: 1529-1535
        • Whitlock EP
        • Garlitz BA
        • Harris EL
        • et al.
        Screening for hereditary hemochromatosis: a systematic review for the U.S. Preventive Services Task Force.
        Ann Intern Med. 2006; 145: 209-223
        • Schmitt B
        • Golub RM
        • Green R.
        Screening primary care patients for hereditary hemochromatosis with transferrin saturation and serum ferritin level: systematic review for the American College of Physicians.
        Ann Intern Med. 2005; 143: 522-536
        • Adams P
        • Barton JC
        • McLaren GD
        • et al.
        Screening for iron overload: lessons from the Hemochromatosis and Iron Overload Screening (HEIRS) Study.
        Can J Gastroenterol. 2009; 23: 769-772
        • Bacon BR
        • Adams PC
        • Kowdley KV
        • et al.
        Diagnosis and management of hemochromatosis: 2011 Practice Guideline by the American Association for the Study of Liver Diseases.
        Hepatology. 2011; 54: 328-343